Vertex Pharma (NASDAQ:VRTX) Is A Stock That Stifel Seems to be Very Interested In
Why Has Stifel Given Vertex Pharma (NASDAQ:VRTX) a $160.0 Price Target Research analysts at Stifel launched coverage on Vertex Pharma (NASDAQ:VRTX) with a key Buy…
Finance
Reaffirmed: FLIR Systems (NASDAQ:FLIR) Buy Rating Has Been Maintained by Needham; $35.0 Target in Place
FLIR Systems (NASDAQ:FLIR) Rating Reaffirmed Professional analysts at Needham now has a $35.0 PT on FLIR Systems (NASDAQ:FLIR). Needham and their recent PT suggests a…
